MedTrace Logo

Collection and Study of Cerebrospinal Fluid in Patients With Hunter Syndrome

NCT01449240 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 10

Last updated 2021-06-09

Study results available
· View outcomes & findings →

Summary

The purpose of the study is to collect data on CSF biomarkers in patients with Hunter Syndrome that would serve as reference data for comparison with cognitively impaired patients with Hunter syndrome, patients with other lysosomal storage diseases, or other diseases with CNS involvement.

Conditions

Interventions

OTHER

No treatment

Sponsors & Collaborators

  • Shire

    lead INDUSTRY

Principal Investigators

  • Study Director · Takeda

Eligibility

Max Age
70 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-11-12
Primary Completion
2013-12-20
Completion
2013-12-20

Countries

  • United States
  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01449240 on ClinicalTrials.gov